Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Beijing ranks #25,855 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 8 technology areas.
- #25,855
- of 49,997 US assignees by volume
- 25th percentile
- by Innovation Score (27.7/100)
- 10.1
- avg claims per patent
- -57%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R25855 · Foreign Corporation #25,855 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 10 grants
- MID-PACK #25,855/49,997
- PHOTO-FINISH Beelinx USA L L C
- CPC-NARROW A61P · 8 areas
- INNOV-THIN 27.7/100
- CLAIMS-PAR 10.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -57% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Beelinx USA, L.L.C. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Beijing’s 27.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Beijing
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Beijing Wantai… · this assignee 28
Beijing Wantai… · this assignee
28 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Beijing's Innovation Score is 27.7/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Beijing?
Each dot is one of Beijing’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Beijing’s own 10.1 claims/patent is at or below the 12.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Beijing's grants concentrate
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 90% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2022. By volume, Beijing sits between Beelinx USA, L.L.C. and Bend Labs, Inc..
Beijing's three-year grant acceleration
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Beijing's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Beelinx USA L L C
Beelinx USA, L.L.C.
10 patents
- Beijing Founder A…
Beijing Founder Apabi Technology Limited
10 patents
- Beijing Friendshi…
Beijing Friendship Hospital, Capital Medical University
10 patents
- Beijing Shunzao T…
Beijing Shunzao Technology Co., Ltd.
10 patents
- Bell Laboratories
Bell Laboratories, Inc.
10 patents
- Bellco S R L
Bellco S.R.L.
10 patents
- Belletorus
BelleTorus Corporation
10 patents
- Bend Labs
Bend Labs, Inc.
10 patents
- Beijing Wantai Bi… ◀
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
10 patents
What this shows Beijing holds 10 patents at rank #25,893, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Beijing
By rank, the assignees closest to #25,893 in granted patent volume.
- Beelinx USA, L.L.C. #25,889 · 10 patents
- Beijing Founder Apabi Technology Limited #25,890 · 10 patents
- Beijing Friendship Hospital, Capital Medical University #25,891 · 10 patents
- Beijing Shunzao Technology Co., Ltd. #25,892 · 10 patents
- Bell Laboratories, Inc. #25,894 · 10 patents
- Bellco S.R.L. #25,895 · 10 patents
- BelleTorus Corporation #25,896 · 10 patents
- Bend Labs, Inc. #25,897 · 10 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Beijing's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Beijing's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 25th percentile higher than 25% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 30.0% |
| 2017 | 2 | 20.0% |
| 2018 | 2 | 20.0% |
| 2020 | 2 | 20.0% |
| 2022 | 1 | 10.0% |
Which technologies does Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s patent record in context - here's where to go next.
- Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #25,855 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. against Beelinx USA, L.L.C., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 27.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.